Combination Therapy
Showing 9951 - 9975 of >10,000
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Iron Deficiency Anemia Due to Blood Loss, Aortic Stenosis Trial in Haifa (IV Sodium Ferric Gluconate Complex)
Recruiting
- Iron Deficiency Anemia Due to Blood Loss
- Aortic Stenosis
- IV Sodium Ferric Gluconate Complex
-
Haifa, IsraelRambam Medical Center
Oct 25, 2022
Bulimia Nervosa, Binge-Eating Disorder Trial in Milano (tVNS, rTMS, CBT-E)
Recruiting
- Bulimia Nervosa
- Binge-Eating Disorder
- tVNS
- +2 more
-
Milano, ItalyFondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Apr 14, 2022
Anemia, Sickle Cell Trial in Oakland (alpha-lipoic acid and acetyl-L-carnitine, Control)
Completed
- Anemia, Sickle Cell
- alpha-lipoic acid and acetyl-L-carnitine
- Control
-
Oakland, CaliforniaChildren's Hospital & Research Center Oakland
Jul 13, 2021
Cervical Cancer Trial in Providence (Nivolumab induction, Cisplatin, Radiation)
Terminated
- Cervical Cancer
- Nivolumab induction
- +4 more
-
Providence, Rhode Island
- +1 more
Mar 30, 2022
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Malignant Solid Neoplasm
- Alisertib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)
Recruiting
- Lung Cancer Squamous Cell
- +3 more
-
Boston, Massachusetts
- +2 more
Jan 9, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Iadademstat
- Gilteritinib Oral Tablet
-
Boston, Massachusetts
- +2 more
Jan 18, 2023
NSCLC (NSCLC) Trial in Worldwide (Tislelizumab, Docetaxel, Sitravatinib)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Tislelizumab
- +2 more
-
Tucson, Arizona
- +112 more
Nov 9, 2022
Immune Checkpoint Inhibitors and Chemotherapy for Advanced
Completed
- Esophageal Cancer
-
Guangzhou, Guangdong, China
- +1 more
Mar 15, 2022
Immunotherapy Trial in France (olaparib, durvalumab, tremelimumab)
Recruiting
- Immunotherapy
- olaparib, durvalumab, tremelimumab
-
Amiens, France
- +7 more
May 21, 2021
Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)
Not yet recruiting
- Hodgkin Lymphoma
- +2 more
- Mosunetuzumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 7, 2022
3D Specimen Maps for RT Planning
Recruiting
- Head and Neck Cancer
- +2 more
-
Nashville, TennesseeVanderbilt Medical Center
Feb 23, 2023
Plasmodium Falciparum Infection Trial in Worldwide (Artefenomel (OZ439), Ferroquine (SSR97193))
Completed
- Plasmodium Falciparum Infection
- Artefenomel (OZ439)
- Ferroquine (SSR97193)
-
Cotonou, Benin
- +6 more
Mar 10, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Cocaine Use Disorder, Cocaine Dependence Trial in Zürich (Ketamine, Placebo, real-time fMRI neurofeedback training)
Not yet recruiting
- Cocaine Use Disorder
- Cocaine Dependence
- Ketamine
- +3 more
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich, University of Zurich
Nov 6, 2023
Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 21, 2022
Leg Ulcer Trial in Praha (Sevoflurane, Cyteal)
Recruiting
- Leg Ulcer
- Sevoflurane
- Cyteal
-
Praha, CzechiaFaculty Hospital Kralovske Vinohrady
May 19, 2022
Rectal Cancer Trial in Moscow (combination product, procedure, drug)
Recruiting
- Rectal Cancer
- Concurrent Chemoradiotherapy
- +3 more
-
Moscow, Russian FederationState Scientific Centre of Coloproctology
Feb 10, 2021
Multiple Sclerosis Trial (Dalfampridine Pill, Placebo)
Completed
- Multiple Sclerosis
- Dalfampridine Pill
- Placebo
- (no location specified)
May 5, 2023
Type 2 Diabetes Trial in Jilin (Rongliflozin, Rifampin, Probenecid)
Completed
- Type 2 Diabetes Mellitus
- Rongliflozin
- +2 more
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Aug 9, 2022
MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- decitabine
- +5 more
- (no location specified)
Aug 5, 2022